SEP 17, 2026 · JOURNAL ARTICLE
SINTILIMAB PLUS CHEMOTHERAPY IN UNRESECTABLE GASTRIC/GEJ CANCER: A RETROSPECTIVE SAFETY AND EFFICACY ANALYSIS
Eurasia Journal of Science and Technology
To compare overall survival and safety of patients with metastatic gastric and gastroesophageal junction cancers treated with sintilimab with chemotherapy vs. chemotherapy only. In